Stable nanoparticles train the immune system to fight cancer
Over the past decade, researchers have sought more effective and enduring cancer treatments. Among the wide variety of immunotherapies, Stimulator of Interfron Genes activation (STING agonism) has emerged as a particularly promising approach that harnesses a patient’s immune system to combat tumors throughout the body.
Pere Dosta Pons Lily Ramsey Natalie Artzi Cell Therapy Institute Brigham Department Of Medicine Interfron Genes
Source: news-medical.net